Trials / Unknown
UnknownNCT01771978
Ischaemia-réperfusion During the Coronary Surgery With Beating Heart
Effects of Diltiazem and/or N-Acétylcystéine Versus Placebo on hémodynamiques and Biological Repercussions of the Ischaemia-réperfusion During the Coronary Surgery With Beating Heart
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Less oxidative stress occurs during off-pump than on-pump coronary artery bypass graft (CABG) surgery but warm ischaemia-reperfusion injury may occur following transient coronary artery clamping. The aim of this study was to compare the preventive effects of diltiazem and N-acetylcysteine (NAC), alone or in combination, on biomarkers of myocardial damage and oxidative stress during off-pump CABG surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Received 250 ml of a 5% dextrose solution as placebo |
| DRUG | Diltiazem | Received a 100 µg/kg bolus followed by a 0.3 µg/kg infusion diluted in 250 ml of 5% dextrose solution |
| DRUG | Acetylcystein | Received 150 mg/kg acetylcystein diluted in 250 ml of 5% dextrose solution |
| DRUG | diltiazem and acetylcystein | Received a combination of drug :diltiazem and acetylcystein * bolus diltiazem 100 µg/kg followed by a 0.3 µg/kg infusion diluted in 125 ml of a 5% dextrose solution * 150 mg/kg acetylcystein diluted in 125 ml of 5% dextrose solution |
Timeline
- Start date
- 2002-06-01
- Primary completion
- 2008-02-01
- First posted
- 2013-01-18
- Last updated
- 2013-01-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01771978. Inclusion in this directory is not an endorsement.